These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9225277)

  • 1. Differential effects of 5-HT1B/1D receptor agonists on neurogenic dural plasma extravasation and vasodilation in anaesthetized rats.
    Shepherd SL; Williamson DJ; Beer MS; Hill RG; Hargreaves RJ
    Neuropharmacology; 1997; 36(4-5):525-33. PubMed ID: 9225277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-Carboxamido-tryptamine, CP-122,288 and dihydroergotamine but not sumatriptan, CP-93,129, and serotonin-5-O-carboxymethyl-glycyl -tyrosinamide block dural plasma protein extravasation in knockout mice that lack 5-hydroxytryptamine1B receptors.
    Yu XJ; Waeber C; Castanon N; Scearce K; Hen R; Macor JE; Chauveau J; Moskowitz MA
    Mol Pharmacol; 1996 May; 49(5):761-5. PubMed ID: 8622623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The in vivo pharmacological profile of a 5-HT1 receptor agonist, CP-122,288, a selective inhibitor of neurogenic inflammation.
    Gupta P; Brown D; Butler P; Ellis P; Grayson KL; Land GC; Macor JE; Robson SF; Wythes MJ; Shepperson NB
    Br J Pharmacol; 1995 Nov; 116(5):2385-90. PubMed ID: 8581273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 5-HT1D receptor antagonist GR-127,935 prevents inhibitory effects of sumatriptan but not CP-122,288 and 5-CT on neurogenic plasma extravasation within guinea pig dura mater.
    Yu XJ; Cutrer FM; Moskowitz MA; Waeber C
    Neuropharmacology; 1997 Jan; 36(1):83-91. PubMed ID: 9144644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The in vivo pharmacological profile of eletriptan (UK-116,044): a potent and novel 5-HT(1B/1D) receptor agonist.
    Gupta P; Butler P; Shepperson NB; McHarg A
    Eur J Pharmacol; 2000 Jun; 398(1):73-81. PubMed ID: 10856450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent blockade of neurogenic plasma extravasation in dura mater by 5-HT1B/D agonists and endopeptidase 24.11.
    Huang Z; Byun B; Matsubara T; Moskowitz MA
    Br J Pharmacol; 1993 Feb; 108(2):331-5. PubMed ID: 8383561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human 5-HT1F receptor-stimulated [35S]GTPgammaS binding: correlation with inhibition of guinea pig dural plasma protein extravasation.
    Wainscott DB; Johnson KW; Phebus LA; Schaus JM; Nelson DL
    Eur J Pharmacol; 1998 Jul; 352(1):117-24. PubMed ID: 9718276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The anti-migraine 5-HT(1B/1D) agonist rizatriptan inhibits neurogenic dural vasodilation in anaesthetized guinea-pigs.
    Williamson DJ; Hill RG; Shepheard SL; Hargreaves RJ
    Br J Pharmacol; 2001 Aug; 133(7):1029-34. PubMed ID: 11487512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Further characterization of the putative 5-HT receptor which mediates blockade of neurogenic plasma extravasation in rat dura mater.
    Buzzi MG; Moskowitz MA; Peroutka SJ; Byun B
    Br J Pharmacol; 1991 Jun; 103(2):1421-8. PubMed ID: 1653072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor specificity and trigemino-vascular inhibitory actions of a novel 5-HT1B/1D receptor partial agonist, 311C90 (zolmitriptan).
    Martin GR; Robertson AD; MacLennan SJ; Prentice DJ; Barrett VJ; Buckingham J; Honey AC; Giles H; Moncada S
    Br J Pharmacol; 1997 May; 121(2):157-64. PubMed ID: 9154322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How efficacious are 5-HT1B/D receptor ligands: an answer from GTP gamma S binding studies with stably transfected C6-glial cell lines.
    Pauwels PJ; Tardif S; Palmier C; Wurch T; Colpaert FC
    Neuropharmacology; 1997; 36(4-5):499-512. PubMed ID: 9225275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurogenic inflammation in the context of migraine.
    Williamson DJ; Hargreaves RJ
    Microsc Res Tech; 2001 May; 53(3):167-78. PubMed ID: 11301492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pre- and postjunctional activity of CP-122,288, a conformationally restricted analogue of sumatriptan.
    Beattie DT; Connor HE
    Eur J Pharmacol; 1995 Apr; 276(3):271-6. PubMed ID: 7601213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the effects of sumatriptan and the NK1 antagonist CP-99,994 on plasma extravasation in Dura mater and c-fos mRNA expression in trigeminal nucleus caudalis of rats.
    Shepheard SL; Williamson DJ; Williams J; Hill RG; Hargreaves RJ
    Neuropharmacology; 1995 Mar; 34(3):255-61. PubMed ID: 7630480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel anti-migraine agent rizatriptan inhibits neurogenic dural vasodilation and extravasation.
    Williamson DJ; Shepheard SL; Hill RG; Hargreaves RJ
    Eur J Pharmacol; 1997 Jun; 328(1):61-4. PubMed ID: 9203569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of PNU-109,291, a selective 5-HT1D receptor agonist, on electrically induced dural plasma extravasation and capsaicin-evoked c-fos immunoreactivity within trigeminal nucleus caudalis.
    Cutrer FM; Yu XJ; Ayata G; Moskowitz MA; Waeber C
    Neuropharmacology; 1999 Jul; 38(7):1043-53. PubMed ID: 10428423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
    Buzzi MG; Moskowitz MA
    Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dural vasodilation causes a sensitization of rat caudal trigeminal neurones in vivo that is blocked by a 5-HT1B/1D agonist.
    Cumberbatch MJ; Williamson DJ; Mason GS; Hill RG; Hargreaves RJ
    Br J Pharmacol; 1999 Mar; 126(6):1478-86. PubMed ID: 10217543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-HT7 receptors are involved in neurogenic dural vasodilatation in an experimental model of migraine.
    Wang X; Fang Y; Liang J; Yan M; Hu R; Pan X
    J Mol Neurosci; 2014; 54(2):164-70. PubMed ID: 24584680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CP-93,129, a potent and selective 5-HT1B receptor agonist blocks neurogenic plasma extravasation within rat but not guinea-pig dura mater.
    Matsubara T; Moskowitz MA; Byun B
    Br J Pharmacol; 1991 Sep; 104(1):3-4. PubMed ID: 1664765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.